APA (7th ed.) Citation

JE, P., JP, S., DD, S., SM, C., CD, B., TA, W., . . . JA, V. (2022). Surface Modification of Biodegradable Microparticles with the Novel Host-Derived Immunostimulant CPDI-02 Significantly Increases Short-Term and Long-Term Mucosal and Systemic Antibodies against Encapsulated Protein Antigen in Young Naïve Mice after Respiratory Immunization. Pharmaceutics, 14(9), . https://doi.org/10.3390/pharmaceutics14091843

Chicago Style (17th ed.) Citation

JE, Parriott, et al. "Surface Modification of Biodegradable Microparticles with the Novel Host-Derived Immunostimulant CPDI-02 Significantly Increases Short-Term and Long-Term Mucosal and Systemic Antibodies Against Encapsulated Protein Antigen in Young Naïve Mice After Respiratory Immunization." Pharmaceutics 14, no. 9 (2022). https://doi.org/10.3390/pharmaceutics14091843.

MLA (9th ed.) Citation

JE, Parriott, et al. "Surface Modification of Biodegradable Microparticles with the Novel Host-Derived Immunostimulant CPDI-02 Significantly Increases Short-Term and Long-Term Mucosal and Systemic Antibodies Against Encapsulated Protein Antigen in Young Naïve Mice After Respiratory Immunization." Pharmaceutics, vol. 14, no. 9, 2022, https://doi.org/10.3390/pharmaceutics14091843.